Product Description
This up-to-date and comprehensive set of two CD-ROM discs provides a superb collection of official Federal government documents on the subject of ALS. Amyotrophic lateral sclerosis (ALS) is a nervous system disease that attacks nerve cells called neurons in the brain and spinal cord. These neurons transmit messages from the brain and spinal cord to the voluntary muscles - such as those in the arms and legs. At first, this causes mild muscle problems. Some people notice trouble walking or running; trouble writing; or speech problems. Eventually, the patient loses strength and cannot move. When muscles in the chest fail, the patient cannot breathe. A ventilator can help, but most people with ALS die from respiratory failure.For patients, practical information is provided in clearly written patient education documents. For medical professionals, doctor reference tools and texts have detailed technical information and clinical background material. There is no other reference that is as fast, convenient, and portable - everything you need to know, from the federal sources you trust. This thoroughly researched collection presents vital information from many authoritative sources: Food and Drug Administration (FDA), Centers for Disease Control (CDC), National Institutes of Health (NIH) and the relevant institute for this disease, and others.In addition to the comprehensive disease-specific coverage, this disc set also includes our Medical Encyclopedia, a $19.95 value! The Encyclopedia presents a collection of official documents about a wide range of medical topics, diseases, illnesses, health and wellness. There is vital information from the National Institutes of Health (NIH), the Centers for Disease Control (CDC), National Cancer Institute, and more. Topics covered include: major diseases, including cancer, heart and vascular disease, stroke, blood diseases and disorders, lung diseases, and neurological disorders such as dementia and epilepsy * CDC Health Topics A to Z, Foodborne Illnesses, Infants and Children, Injuries, Occupational Health, Older Adults, Women * CDC Travelers' Health - Destinations, Vaccinations, Diseases, Mosquito, Tick, Food, Water, Clinics, Yellow Book, Children, Airplanes, Cruise Ships, Special Needs, Relief Workers, * Dietary Guidelines * NIH A to Z from abnormalities to X-rays.Since navigating the Internet to find additional non-governmental medical information can be confusing, we've also provided our exclusive "Guide to Leading Medical Websites" with updated links to 67 of the best sites for medical information! Built-in weblinks let you quickly check for the latest clinical updates directly from the government and the best commercial portals, news sites, reference/textbook/non-commercial portals, and health organizations. ... Read more

Product Description
This digital document is an article from Journal of Neuroscience Nursing, published by American Association of Neuroscience Nurses on August 1, 1998. The length of the article is 2573 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

From the supplier: The Food and Drug Administration approved Riluzole for the management of amyotrophic lateral sclerosis (ALS) in 1995, a motor neuron disease leading to the loss of impulse transmission. One hypothesis for this disease suggests that glutamate, an excitatory neurotransmitter, injures the motor neurons and Riluzole is thought to decrease the release of glutamate into the intracellular space. Riluzole has been shown to increase ALS sufferers' survival time. Its mechanism of action, pharmacokinetics, dosage and contraindications and warnings are summarized.

Citation Details
Title: Management of amyotrophic lateral sclerosis with Riluzole.
Author: Jacquelin S. Neatherlin
Publication: Journal of Neuroscience Nursing (Refereed)
Date: August 1, 1998
Publisher: American Association of Neuroscience Nurses
Volume: v30Issue: n4Page: p257(4)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Journal of Medical Speech - Language Pathology, published by Delmar Learning on September 1, 2010. The length of the article is 7714 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Eye-gaze access to AAC technology for people with amyotrophic lateral sclerosis.(augmentative and alternative communication)(Report)
Author: Laura J. Ball
Publication: Journal of Medical Speech - Language Pathology (Magazine/Journal)
Date: September 1, 2010
Publisher: Delmar Learning
Volume: 18Issue: 3Page: 11(13)

Article Type: Report

Distributed by Gale, a part of Cengage Learning ... Read more

Product Description
This digital document is an article from FOCUS: Journal for Respiratory Care & Sleep Medicine, published by Focus Publications, Inc. on November 1, 2008. The length of the article is 1368 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Amyotrophic lateral sclerosis.(RESPIRATORY CLINICAL KEEPER)
Author: Bill Wojciechowski
Publication: FOCUS: Journal for Respiratory Care & Sleep Medicine (Magazine/Journal)
Date: November 1, 2008
Publisher: Focus Publications, Inc.
Page: 24(2)

Distributed by Gale, a part of Cengage Learning ... Read more

Product Description
This digital document is a journal article from Neuropsychologia, published by Elsevier in 2005. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
The current study sought to examine the performance of non-demented ALS patients on neuropsychological tests involving emotional perception and memory. Nineteen non-demented patients with ALS were compared with 20 healthy controls on assessments of facial expression recognition, social judgement ratings of faces and recognition memory for emotional words. Patients and controls were well matched to exclude a range of potentially confounding variables. The patients and controls demonstrated significant differences on only one test of cognitive functioning. The ALS group demonstrated a failure to show the normative pattern of enhanced recognition memory for emotional words compared to neutral words and produced higher scores than controls on recognition memory for neutral words. These findings suggest that patients with ALS show a different pattern of cognitive performance with respect to memory for emotional material when compared to healthy adults. ... Read more

Product Description
Amyotrophic Lateral Sclerosis. Motor neurone disease, Jean- Martin Charcot, Neurodegenerative disease, Lou Gehrig, Stephen Hawking, Jason Becker, Fasciculation, Atrophy, Frontotemporal dementia, Dysphagia, Dysarthria, Spasticity, Hyperreflexia, Plantar reflex, Labile affect, Palliative care, ALS Association, ALS Therapy Development Institute, ALS Society of Canada ... Read more